Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database

Background In response to the increasing concern with the safety of the drug-eluting stent (DES), the present study aimed to evaluate the long-term safety and efficacy of DES used for a Chinese patient population. Methods All patients, who underwent an index elective percutaneous coronary interventi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese medical journal 2009-10, Vol.122 (19), p.2261-2267
Hauptverfasser: Gao, Run-lin, Xu, Bo, Chen, Ji-lin, Yang, Yue-jin, Qiao, Shu-bin, Wang, Yang, Dou, Ke-fei, Qin, Xue-wen, Yao, Min, Liu, Hai-bo, Wu, Yong-jian, Yuan, Jin-qing, Chen, Jue, You, Shi-jie, Dai, Jun, Ma, Wei-hua, Li, Wei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2267
container_issue 19
container_start_page 2261
container_title Chinese medical journal
container_volume 122
creator Gao, Run-lin
Xu, Bo
Chen, Ji-lin
Yang, Yue-jin
Qiao, Shu-bin
Wang, Yang
Dou, Ke-fei
Qin, Xue-wen
Yao, Min
Liu, Hai-bo
Wu, Yong-jian
Yuan, Jin-qing
Chen, Jue
You, Shi-jie
Dai, Jun
Ma, Wei-hua
Li, Wei
description Background In response to the increasing concern with the safety of the drug-eluting stent (DES), the present study aimed to evaluate the long-term safety and efficacy of DES used for a Chinese patient population. Methods All patients, who underwent an index elective percutaneous coronary intervention with an implantation of either DES or bare-metal stent (BMS) in a single institution from April 2004 to December 2006, were included in the analysis. A propensity-score matching technique was applied to adjust and to minimize the impact of confounding factors. Results Overall, there were 1465 patients (20.2%) who had undergone an implantation of only BMS, and 5769 patients (79.8%) of only DES. The propensity-score matching technique set up 1321 pairs of patients for analysis. There were no significant differences between the rates of stent thrombosis (definite and probable) of the two groups (1.06% vs 1.21%, P=0.8580). Although rates of mortality and myocardial infarction (MI) during the 2-year follow-up period had not differed significantly, rates of death/MI (3.0% vs 4.5%, P=0.0263), target-lesion revascularization (TLR, 3.2% vs 8.5, P=0.0001), target-vessel revascularization (TVR, 5.8% vs 9.5%, P 〈0.0001) and any revascularization (10.0% vs 13.3%, P=0.0066) were significantly lower for the DES group than for the BMS group. Among the patients in whom devices were implanted for off-label indications, the propensity-score matched rates of stent thrombosis, mortality, MI, and death/MI were not significantly different, while rates of TLR, TVR and any revascularization were significantly lower for the DES group than for the BMS group. Conclusions During the 2 years of follow-up post stenting, DES use is associated with lower rates of death/MI, TLR, TVR and any revascularization, compared with BMS, in propensity-score matched Chinese patient populations. In the setting of off-label usage, DES use is also associated with similar advantages.
doi_str_mv 10.3760/cma.j.issn.0366-6999.2009.19.015
format Article
fullrecord <record><control><sourceid>wanfang_jour_proqu</sourceid><recordid>TN_cdi_wanfang_journals_zhcmj200919015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>32512193</cqvip_id><wanfj_id>zhcmj200919015</wanfj_id><sourcerecordid>zhcmj200919015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c268t-70c582adeab2ddcece0bb82a534f24099ce3603541e3125ca13cb5f831d3a6443</originalsourceid><addsrcrecordid>eNo9kE1u1TAUhS1ERR-FLSCLATBJ8E-cPA9RxZ9UqZMyjm6cm9QPx361nT6VRbAA1sKeuoW6eoXRlY6-c67OIeQDZ7XsWvbRLFDvapuSr5ls26rVWteCMV1zXTOunpGNUI2oVNvw52TznzklL1PaMSaU6toX5LRYOs1FsyG_rw6hukOI1DjrrQFHw5pNWDDRKTgXDtbPFB2abG-RjnGdK3RrflRvMaY10QEiVgvmYk0ZfaZ22TvwGbIN_v7vHxoxrS6XvBgWCtRBnJGmkuCwMsWAkY6QYYCEr8jJBC7h66d7Rn58-Xx1_q26uPz6_fzTRWVEu81Vx4zaChgRBjGOBg2yYSiCks0kGqa1QdkyqRqOkgtlgEszqGkr-SihbRp5Rt4dcw_gJ_Bzvwtr9OVj_-vaLLvHSbkugxbw_RHcx3CzYsr9YpNBVwpiWFPfSdnxRjNdyDdP5DosOPb7aBeId_2_rQvw9giY6-Dnm9K_H8D8nKzDXgrFBddSPgBEuZVE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733714909</pqid></control><display><type>article</type><title>Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gao, Run-lin ; Xu, Bo ; Chen, Ji-lin ; Yang, Yue-jin ; Qiao, Shu-bin ; Wang, Yang ; Dou, Ke-fei ; Qin, Xue-wen ; Yao, Min ; Liu, Hai-bo ; Wu, Yong-jian ; Yuan, Jin-qing ; Chen, Jue ; You, Shi-jie ; Dai, Jun ; Ma, Wei-hua ; Li, Wei</creator><creatorcontrib>Gao, Run-lin ; Xu, Bo ; Chen, Ji-lin ; Yang, Yue-jin ; Qiao, Shu-bin ; Wang, Yang ; Dou, Ke-fei ; Qin, Xue-wen ; Yao, Min ; Liu, Hai-bo ; Wu, Yong-jian ; Yuan, Jin-qing ; Chen, Jue ; You, Shi-jie ; Dai, Jun ; Ma, Wei-hua ; Li, Wei</creatorcontrib><description>Background In response to the increasing concern with the safety of the drug-eluting stent (DES), the present study aimed to evaluate the long-term safety and efficacy of DES used for a Chinese patient population. Methods All patients, who underwent an index elective percutaneous coronary intervention with an implantation of either DES or bare-metal stent (BMS) in a single institution from April 2004 to December 2006, were included in the analysis. A propensity-score matching technique was applied to adjust and to minimize the impact of confounding factors. Results Overall, there were 1465 patients (20.2%) who had undergone an implantation of only BMS, and 5769 patients (79.8%) of only DES. The propensity-score matching technique set up 1321 pairs of patients for analysis. There were no significant differences between the rates of stent thrombosis (definite and probable) of the two groups (1.06% vs 1.21%, P=0.8580). Although rates of mortality and myocardial infarction (MI) during the 2-year follow-up period had not differed significantly, rates of death/MI (3.0% vs 4.5%, P=0.0263), target-lesion revascularization (TLR, 3.2% vs 8.5, P=0.0001), target-vessel revascularization (TVR, 5.8% vs 9.5%, P 〈0.0001) and any revascularization (10.0% vs 13.3%, P=0.0066) were significantly lower for the DES group than for the BMS group. Among the patients in whom devices were implanted for off-label indications, the propensity-score matched rates of stent thrombosis, mortality, MI, and death/MI were not significantly different, while rates of TLR, TVR and any revascularization were significantly lower for the DES group than for the BMS group. Conclusions During the 2 years of follow-up post stenting, DES use is associated with lower rates of death/MI, TLR, TVR and any revascularization, compared with BMS, in propensity-score matched Chinese patient populations. In the setting of off-label usage, DES use is also associated with similar advantages.</description><identifier>ISSN: 0366-6999</identifier><identifier>EISSN: 2542-5641</identifier><identifier>DOI: 10.3760/cma.j.issn.0366-6999.2009.19.015</identifier><identifier>PMID: 20079124</identifier><language>eng</language><publisher>China: Department of Cardiology ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China%Catheterization Laboratory ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China%Division of Biometrics ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China</publisher><subject>Adult ; Aged ; Angioplasty, Balloon, Coronary - mortality ; Databases, Factual ; Drug-Eluting Stents - adverse effects ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myocardial Infarction - mortality ; Stents - adverse effects ; 中心数据库 ; 金属支架</subject><ispartof>Chinese medical journal, 2009-10, Vol.122 (19), p.2261-2267</ispartof><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/85656X/85656X.jpg</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20079124$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gao, Run-lin</creatorcontrib><creatorcontrib>Xu, Bo</creatorcontrib><creatorcontrib>Chen, Ji-lin</creatorcontrib><creatorcontrib>Yang, Yue-jin</creatorcontrib><creatorcontrib>Qiao, Shu-bin</creatorcontrib><creatorcontrib>Wang, Yang</creatorcontrib><creatorcontrib>Dou, Ke-fei</creatorcontrib><creatorcontrib>Qin, Xue-wen</creatorcontrib><creatorcontrib>Yao, Min</creatorcontrib><creatorcontrib>Liu, Hai-bo</creatorcontrib><creatorcontrib>Wu, Yong-jian</creatorcontrib><creatorcontrib>Yuan, Jin-qing</creatorcontrib><creatorcontrib>Chen, Jue</creatorcontrib><creatorcontrib>You, Shi-jie</creatorcontrib><creatorcontrib>Dai, Jun</creatorcontrib><creatorcontrib>Ma, Wei-hua</creatorcontrib><creatorcontrib>Li, Wei</creatorcontrib><title>Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database</title><title>Chinese medical journal</title><addtitle>Chinese Medical Journal</addtitle><description>Background In response to the increasing concern with the safety of the drug-eluting stent (DES), the present study aimed to evaluate the long-term safety and efficacy of DES used for a Chinese patient population. Methods All patients, who underwent an index elective percutaneous coronary intervention with an implantation of either DES or bare-metal stent (BMS) in a single institution from April 2004 to December 2006, were included in the analysis. A propensity-score matching technique was applied to adjust and to minimize the impact of confounding factors. Results Overall, there were 1465 patients (20.2%) who had undergone an implantation of only BMS, and 5769 patients (79.8%) of only DES. The propensity-score matching technique set up 1321 pairs of patients for analysis. There were no significant differences between the rates of stent thrombosis (definite and probable) of the two groups (1.06% vs 1.21%, P=0.8580). Although rates of mortality and myocardial infarction (MI) during the 2-year follow-up period had not differed significantly, rates of death/MI (3.0% vs 4.5%, P=0.0263), target-lesion revascularization (TLR, 3.2% vs 8.5, P=0.0001), target-vessel revascularization (TVR, 5.8% vs 9.5%, P 〈0.0001) and any revascularization (10.0% vs 13.3%, P=0.0066) were significantly lower for the DES group than for the BMS group. Among the patients in whom devices were implanted for off-label indications, the propensity-score matched rates of stent thrombosis, mortality, MI, and death/MI were not significantly different, while rates of TLR, TVR and any revascularization were significantly lower for the DES group than for the BMS group. Conclusions During the 2 years of follow-up post stenting, DES use is associated with lower rates of death/MI, TLR, TVR and any revascularization, compared with BMS, in propensity-score matched Chinese patient populations. In the setting of off-label usage, DES use is also associated with similar advantages.</description><subject>Adult</subject><subject>Aged</subject><subject>Angioplasty, Balloon, Coronary - mortality</subject><subject>Databases, Factual</subject><subject>Drug-Eluting Stents - adverse effects</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - mortality</subject><subject>Stents - adverse effects</subject><subject>中心数据库</subject><subject>金属支架</subject><issn>0366-6999</issn><issn>2542-5641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1u1TAUhS1ERR-FLSCLATBJ8E-cPA9RxZ9UqZMyjm6cm9QPx361nT6VRbAA1sKeuoW6eoXRlY6-c67OIeQDZ7XsWvbRLFDvapuSr5ls26rVWteCMV1zXTOunpGNUI2oVNvw52TznzklL1PaMSaU6toX5LRYOs1FsyG_rw6hukOI1DjrrQFHw5pNWDDRKTgXDtbPFB2abG-RjnGdK3RrflRvMaY10QEiVgvmYk0ZfaZ22TvwGbIN_v7vHxoxrS6XvBgWCtRBnJGmkuCwMsWAkY6QYYCEr8jJBC7h66d7Rn58-Xx1_q26uPz6_fzTRWVEu81Vx4zaChgRBjGOBg2yYSiCks0kGqa1QdkyqRqOkgtlgEszqGkr-SihbRp5Rt4dcw_gJ_Bzvwtr9OVj_-vaLLvHSbkugxbw_RHcx3CzYsr9YpNBVwpiWFPfSdnxRjNdyDdP5DosOPb7aBeId_2_rQvw9giY6-Dnm9K_H8D8nKzDXgrFBddSPgBEuZVE</recordid><startdate>20091005</startdate><enddate>20091005</enddate><creator>Gao, Run-lin</creator><creator>Xu, Bo</creator><creator>Chen, Ji-lin</creator><creator>Yang, Yue-jin</creator><creator>Qiao, Shu-bin</creator><creator>Wang, Yang</creator><creator>Dou, Ke-fei</creator><creator>Qin, Xue-wen</creator><creator>Yao, Min</creator><creator>Liu, Hai-bo</creator><creator>Wu, Yong-jian</creator><creator>Yuan, Jin-qing</creator><creator>Chen, Jue</creator><creator>You, Shi-jie</creator><creator>Dai, Jun</creator><creator>Ma, Wei-hua</creator><creator>Li, Wei</creator><general>Department of Cardiology ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China%Catheterization Laboratory ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China%Division of Biometrics ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W92</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope></search><sort><creationdate>20091005</creationdate><title>Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database</title><author>Gao, Run-lin ; Xu, Bo ; Chen, Ji-lin ; Yang, Yue-jin ; Qiao, Shu-bin ; Wang, Yang ; Dou, Ke-fei ; Qin, Xue-wen ; Yao, Min ; Liu, Hai-bo ; Wu, Yong-jian ; Yuan, Jin-qing ; Chen, Jue ; You, Shi-jie ; Dai, Jun ; Ma, Wei-hua ; Li, Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c268t-70c582adeab2ddcece0bb82a534f24099ce3603541e3125ca13cb5f831d3a6443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Angioplasty, Balloon, Coronary - mortality</topic><topic>Databases, Factual</topic><topic>Drug-Eluting Stents - adverse effects</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - mortality</topic><topic>Stents - adverse effects</topic><topic>中心数据库</topic><topic>金属支架</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Run-lin</creatorcontrib><creatorcontrib>Xu, Bo</creatorcontrib><creatorcontrib>Chen, Ji-lin</creatorcontrib><creatorcontrib>Yang, Yue-jin</creatorcontrib><creatorcontrib>Qiao, Shu-bin</creatorcontrib><creatorcontrib>Wang, Yang</creatorcontrib><creatorcontrib>Dou, Ke-fei</creatorcontrib><creatorcontrib>Qin, Xue-wen</creatorcontrib><creatorcontrib>Yao, Min</creatorcontrib><creatorcontrib>Liu, Hai-bo</creatorcontrib><creatorcontrib>Wu, Yong-jian</creatorcontrib><creatorcontrib>Yuan, Jin-qing</creatorcontrib><creatorcontrib>Chen, Jue</creatorcontrib><creatorcontrib>You, Shi-jie</creatorcontrib><creatorcontrib>Dai, Jun</creatorcontrib><creatorcontrib>Ma, Wei-hua</creatorcontrib><creatorcontrib>Li, Wei</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-工程技术</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><jtitle>Chinese medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Run-lin</au><au>Xu, Bo</au><au>Chen, Ji-lin</au><au>Yang, Yue-jin</au><au>Qiao, Shu-bin</au><au>Wang, Yang</au><au>Dou, Ke-fei</au><au>Qin, Xue-wen</au><au>Yao, Min</au><au>Liu, Hai-bo</au><au>Wu, Yong-jian</au><au>Yuan, Jin-qing</au><au>Chen, Jue</au><au>You, Shi-jie</au><au>Dai, Jun</au><au>Ma, Wei-hua</au><au>Li, Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database</atitle><jtitle>Chinese medical journal</jtitle><addtitle>Chinese Medical Journal</addtitle><date>2009-10-05</date><risdate>2009</risdate><volume>122</volume><issue>19</issue><spage>2261</spage><epage>2267</epage><pages>2261-2267</pages><issn>0366-6999</issn><eissn>2542-5641</eissn><abstract>Background In response to the increasing concern with the safety of the drug-eluting stent (DES), the present study aimed to evaluate the long-term safety and efficacy of DES used for a Chinese patient population. Methods All patients, who underwent an index elective percutaneous coronary intervention with an implantation of either DES or bare-metal stent (BMS) in a single institution from April 2004 to December 2006, were included in the analysis. A propensity-score matching technique was applied to adjust and to minimize the impact of confounding factors. Results Overall, there were 1465 patients (20.2%) who had undergone an implantation of only BMS, and 5769 patients (79.8%) of only DES. The propensity-score matching technique set up 1321 pairs of patients for analysis. There were no significant differences between the rates of stent thrombosis (definite and probable) of the two groups (1.06% vs 1.21%, P=0.8580). Although rates of mortality and myocardial infarction (MI) during the 2-year follow-up period had not differed significantly, rates of death/MI (3.0% vs 4.5%, P=0.0263), target-lesion revascularization (TLR, 3.2% vs 8.5, P=0.0001), target-vessel revascularization (TVR, 5.8% vs 9.5%, P 〈0.0001) and any revascularization (10.0% vs 13.3%, P=0.0066) were significantly lower for the DES group than for the BMS group. Among the patients in whom devices were implanted for off-label indications, the propensity-score matched rates of stent thrombosis, mortality, MI, and death/MI were not significantly different, while rates of TLR, TVR and any revascularization were significantly lower for the DES group than for the BMS group. Conclusions During the 2 years of follow-up post stenting, DES use is associated with lower rates of death/MI, TLR, TVR and any revascularization, compared with BMS, in propensity-score matched Chinese patient populations. In the setting of off-label usage, DES use is also associated with similar advantages.</abstract><cop>China</cop><pub>Department of Cardiology ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China%Catheterization Laboratory ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China%Division of Biometrics ,Cardiovascular Institute &amp; Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China</pub><pmid>20079124</pmid><doi>10.3760/cma.j.issn.0366-6999.2009.19.015</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0366-6999
ispartof Chinese medical journal, 2009-10, Vol.122 (19), p.2261-2267
issn 0366-6999
2542-5641
language eng
recordid cdi_wanfang_journals_zhcmj200919015
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Angioplasty, Balloon, Coronary - mortality
Databases, Factual
Drug-Eluting Stents - adverse effects
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Infarction - mortality
Stents - adverse effects
中心数据库
金属支架
title Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T17%3A50%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Two-year%20clinical%20outcomes%20following%20elective%20drug-eluting%20versus%20bare-metal%20stent%20implantation%EF%BC%9A%20results%20from%20a%20large%20single-center%20database&rft.jtitle=Chinese%20medical%20journal&rft.au=Gao,%20Run-lin&rft.date=2009-10-05&rft.volume=122&rft.issue=19&rft.spage=2261&rft.epage=2267&rft.pages=2261-2267&rft.issn=0366-6999&rft.eissn=2542-5641&rft_id=info:doi/10.3760/cma.j.issn.0366-6999.2009.19.015&rft_dat=%3Cwanfang_jour_proqu%3Ezhcmj200919015%3C/wanfang_jour_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733714909&rft_id=info:pmid/20079124&rft_cqvip_id=32512193&rft_wanfj_id=zhcmj200919015&rfr_iscdi=true